Anesthesia and Respiratory Devices Market Outline
Anaesthesia devices are utilized amid surgeries to control torment, breathing, pulse, blood stream, and heart rate. A restorative state in patients initiated by utilization of Anaesthesia prompts loss of sensation or mindfulness, which can incorporate absence of pain (alleviation from or avoidance of torment), loss of motion (muscle unwinding), amnesia (loss of memory), or obviousness. Respiratory devices are any equipment or device used for the focused on treatment, diagnosis, management and control of patients with deficiencies of respiratory system. Various devices are used for the management of the respiratory diseases such as COPD and asthma to manage the airflow. Respiratory disorders are one of the leading causes of deaths in world.
Anaesthesia and Respiratory Devices Market Dynamics
The market is driven by the increase in prevalence of respiratory diseases such as chronic obstructive pulmonary disease and asthma world wide. In addition advancements in anaesthesia and respiratory devices such as emergence of portable oxygen concentrators and growing adaptation of anaesthesia and respiratory devices expected to boost the market during the forecast period. Furthermore, increase in levels of air pollution, high prevalence of smoking and growing demand for the point of care devices expected to bolster the market during the forecast period. However, lack of awareness of respiratory conditions and available anaesthesia and respiratory devices expected to hamper the respiratory devices market over the forecast period.
Global Anaesthesia and Respiratory Devices market is expected to grow at significant growth rate owing to prevalence of chronic respiratory diseases. According to World Health Organization (WHO), about 64 Mn people are living with COPD world wide in 2015 and almost 90% of COPD deaths occur in low income countries. The market consists of many big players and small players competing to increase their market share. Companies adopting mergers and acquisitions as their key strategies to improve market share. For instance in May 2017, Royal Philips (Koninklijke Philips N.V.) has signed an agreement to acquire Respiratory Technologies, Inc. to expand its respiratory care business. Furthermore, marketers also focusing on new product development and product launches to maximise their market share. For instance, in February 2015, Lupin Limited launched InspiraChamber under a strategic agreement with IspiRX Inc. in US. This agreement will give Lupin exclusive rights to promote, distribute and market INspiraChamber in US.
Market Scope: Anaesthesia and Respiratory Devices Market
The Market is classified on the basis of product, end user and geographical regions.
Based on Product
- Anaesthesia Devices
- Anaesthesia Disposables
- Respiratory Devices
- Respiratory Disposables
- Respiratory Measurement Devices
Based on End User
- Emergency Medical Services
- Ambulatory Surgical Centers
Geographically Anaesthesia and Respiratory Devices Market is segmented as Latin America, North America, Asia Pacific, the Middle East and Africa and Europe. North American anaesthesia and respiratory devices market expected to register significant growth owing to adaptation of respiratory devices and favourable regulatory environment. Asia Pacific anaesthesia and respiratory devices market is expected to grow at faster rates owing to rise in respiratory disease prevalence, increase in air pollution, developing healthcare infrastructure and low cost of manufacturing of devices in developing regions such as India and China. Latin America & Europe Anaesthesia and Respiratory Devices market is expected to grow at notable rates owing to increase in geriatric population, prevalence of chronic respiratory diseases such as COPD, and growing awareness about the respiratory diseases.
- ResMed Inc. (U.S.)
- Philips Healthcare (Netherlands)
- Medtronic plc (Ireland)
- Fisher and Paykel Healthcare Limited (New Zealand)
- Masimo Corporation (U.S.)
- Lupin Limited (India)
- Becton, Dickinson and Company (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Drägerwerk AG & Co. KGaA (Germany)
- Hamilton Medical AG (Switzerland)
- Chart Industries, Inc. (U.S)